These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37005094)

  • 1. Uptake, experiences and barriers to cervical screening for trans and non-binary people in Aotearoa New Zealand.
    Carroll R; Tan KKH; Ker A; Byrne JL; Veale JF
    Aust N Z J Obstet Gynaecol; 2023 Jun; 63(3):448-453. PubMed ID: 37005094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attitudes of transgender men and non-binary people to cervical screening: a cross-sectional mixed-methods study in the UK.
    Berner AM; Connolly DJ; Pinnell I; Wolton A; MacNaughton A; Challen C; Nambiar K; Bayliss J; Barrett J; Richards C
    Br J Gen Pract; 2021 Aug; 71(709):e614-e625. PubMed ID: 34001539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical Cancer Screening Preferences Among Trans-Masculine Individuals: Patient-Collected Human Papillomavirus Vaginal Swabs Versus Provider-Administered Pap Tests.
    McDowell M; Pardee DJ; Peitzmeier S; Reisner SL; Agénor M; Alizaga N; Bernstein I; Potter J
    LGBT Health; 2017 Aug; 4(4):252-259. PubMed ID: 28665783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barriers and facilitators to cervical cancer screening among transgender men and non-binary people with a cervix: A systematic narrative review.
    Connolly D; Hughes X; Berner A
    Prev Med; 2020 Jun; 135():106071. PubMed ID: 32243938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgender and non-binary peoples experiences of cervical cancer screening: A scoping review.
    Rivers G; Hinchliff S; Thompson J
    J Clin Nurs; 2024 Jun; 33(6):2112-2122. PubMed ID: 38334194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "I teach them. I have no choice": experiences of primary care among transgender people in Aotearoa New Zealand.
    Tan KKH; Carroll R; Treharne GJ; Byrne JL; Veale JF
    N Z Med J; 2022 Aug; 135(1559):59-72. PubMed ID: 35999782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PrEP awareness and protective barrier negotiation among transgender people attracted to men in Aotearoa New Zealand.
    Byrne JL; Tan KKH; Saxton PJ; Bentham RM; Veale JF
    J Int AIDS Soc; 2022 Oct; 25 Suppl 5(Suppl 5):e25980. PubMed ID: 36225159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Test performance and acceptability of self- versus provider-collected swabs for high-risk HPV DNA testing in female-to-male trans masculine patients.
    Reisner SL; Deutsch MB; Peitzmeier SM; White Hughto JM; Cavanaugh TP; Pardee DJ; McLean SA; Panther LA; Gelman M; Mimiaga MJ; Potter JE
    PLoS One; 2018; 13(3):e0190172. PubMed ID: 29538411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceptions of Transgender and Nonbinary Persons Toward Breast and Cervical Cancer Development, Screening, and Potential Impact on Gender-Affirming Hormone Therapy.
    Roznovjak D; Petroll AE; Lakatos AEB; Narayan R; Cortina CS
    JCO Oncol Pract; 2023 May; 19(5):e794-e800. PubMed ID: 36800556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives and Experiences of Transgender and Non-binary Individuals on Seeking Urological Care.
    Chung PH; Spigner S; Swaminathan V; Teplitsky S; Frasso R
    Urology; 2021 Feb; 148():47-52. PubMed ID: 33129873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative and mixed analyses to identify factors that affect cervical cancer screening uptake among lesbian and bisexual women and transgender men.
    Johnson MJ; Mueller M; Eliason MJ; Stuart G; Nemeth LS
    J Clin Nurs; 2016 Dec; 25(23-24):3628-3642. PubMed ID: 27240268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender Identity and Non-Binary Presentations in Adolescents Attending Two Specialized Services in Italy.
    Mirabella M; Piras I; Fortunato A; Fisher AD; Lingiardi V; Mosconi M; Ristori J; Speranza AM; Giovanardi G
    J Sex Med; 2022 Jun; 19(6):1035-1048. PubMed ID: 35370103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Single-Center Study of Adherence to Breast Cancer Screening Mammography Guidelines by Transgender and Non-Binary Patients.
    Luehmann N; Ascha M; Chwa E; Hackenberger P; Termanini K; Benning C; Sama D; Felt D; Beach LB; Gupta D; Kulkarni SA; Jordan SW
    Ann Surg Oncol; 2022 Mar; 29(3):1707-1717. PubMed ID: 34704183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers to Possessing Gender-Concordant Identity Documents are Associated with Transgender and Nonbinary People's Mental Health in Aotearoa/New Zealand.
    Tan KKH; Watson RJ; Byrne JL; Veale JF
    LGBT Health; 2022; 9(6):401-410. PubMed ID: 35605017
    [No Abstract]   [Full Text] [Related]  

  • 15. Cervical Cancer Screening with Human Papillomavirus Self-Sampling Among Transgender Men in El Salvador.
    Maza M; Meléndez M; Herrera A; Hernández X; Rodríguez B; Soler M; Alfaro K; Masch R; Conzuelo-Rodríguez G; Obedin-Maliver J; Cremer M
    LGBT Health; 2020; 7(4):174-181. PubMed ID: 32407149
    [No Abstract]   [Full Text] [Related]  

  • 16. Human Papillomavirus (HPV) Self-Sampling among Never-and Under-Screened Indigenous Māori, Pacific and Asian Women in Aotearoa New Zealand: A Feasibility Study.
    Bromhead C; Wihongi H; Sherman SM; Crengle S; Grant J; Martin G; Maxwell A; McPherson G; Puloka '; Reid S; Scott N; Bartholomew K
    Int J Environ Res Public Health; 2021 Sep; 18(19):. PubMed ID: 34639352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Te Ara Waiora-Implementing human papillomavirus (HPV) primary testing to prevent cervical cancer in Aotearoa New Zealand: A protocol for a non-inferiority trial.
    Gibson-Helm M; Slater T; MacDonald EJ; Stevenson K; Adcock A; Geller S; Parag V; Lambert C; Bennett M; Hibma M; Sykes P; Saville M; Hawkes D; Stanton JA; Clueard MA; Jelley G; Lawton B
    PLoS One; 2023; 18(3):e0280643. PubMed ID: 36952546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and minority-stress correlates of past 12-month prescription drug misuse in a national sample of transgender and gender nonbinary adults: Results from the U.S. Transgender Survey.
    Kidd JD; Goetz TG; Shea EA; Bockting WO
    Drug Alcohol Depend; 2021 Feb; 219():108474. PubMed ID: 33360852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical cancer prevention in transgender men: a review.
    Weyers S; Garland SM; Cruickshank M; Kyrgiou M; Arbyn M
    BJOG; 2021 Apr; 128(5):822-826. PubMed ID: 32931650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving Cervical Screening in Trans and Gender-Diverse People.
    Kerr L; Fisher CM; Jones T
    Cancer Nurs; 2022 Jan-Feb 01; 45(1):37-42. PubMed ID: 32976182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.